@article{6300ed7585c94f91bd6bd0876c3eda9d,
title = "The EANM guideline on radioiodine therapy of benign thyroid disease",
abstract = "This document provides the new EANM guideline on radioiodine therapy of benign thyroid disease. Its aim is to guide nuclear medicine physicians, endocrinologists, and practitioners in the selection of patients for radioiodine therapy. Its recommendations on patients{\textquoteright} preparation, empiric and dosimetric therapeutic approaches, applied radioiodine activity, radiation protection requirements, and patients follow-up after administration of radioiodine therapy are extensively discussed.",
keywords = "Dosimetry, Fixed activity, Graves{\textquoteright} disease, Non-toxic goiter, RAI therapy, Toxic nodular goiter",
author = "Alfredo Campenn{\`i} and Avram, {Anca M.} and Verburg, {Frederik A.} and Ioannis Iakovou and Heribert H{\"a}nscheid and {de Keizer}, Bart and {Petranovi{\'c} Ov{\v c}ari{\v c}ek}, Petra and Luca Giovanella",
note = "Funding Information: The guidelines were brought to the attention of the relevant EANM Committees and the National Societies of Nuclear Medicine. The comments and suggestions from the EANM [Physics Committee, Dosimetry Committee, Radiation Protection Committee, Radiopharmaceutical Sciences Committee, Oncology & Theranostics Committee, Paediatrics Committee, Technologist Committee] and the Austrian, Slovak, Italian, Dutch, Serbian, Hellenic, Romanian, Turkish, Latvian, Estonian, Polish, Danish, Hungarian, British, French, North Macedonia, and Belgian National Societies are highly appreciated and have been considered for this Guideline. Publisher Copyright: {\textcopyright} 2023, The Author(s).",
year = "2023",
month = sep,
doi = "10.1007/s00259-023-06274-5",
language = "English",
volume = "50",
pages = "3324--3348",
journal = "European Journal of Nuclear Medicine and Molecular Imaging",
issn = "1619-7070",
publisher = "Springer-Verlag",
number = "11",
}